AAIC

The diagnostic firm's approach involves testing for tau that's bound to small lipid particles known as extracellular vesicles using its APEX platform.

Two blood-based biomarkers, percentage of p-tau 217 and amyloid-beta 42/40 ratio, predicted the presence of beta-amyloid plaque in patients' PET scans.